Taurine rescues intervertebral disc degeneration by activating mitophagy through the PINK1/Parkin pathway.

Shengyuan Lin, Tao Li, Bin Zhang, Peng Wang

Department of Orthopaedics, Changsha Hospital of Traditional Chinese Medicine (Changsha Eighth Hospital), Changsha, 410199, China. Electronic address: [email protected]. · pubmed

Paper

Abstract

Intervertebral disc degeneration (IDD) is a common cause of low back pain and disability. Recent studies have highlighted the critical role of mitochondrial dysfunction in the progression of IDD. In this study, we investigated the therapeutic potential of taurine in delaying IDD through the activation of mitophagy via the PINK1/Parkin pathway. Our in vitro and in vivo experiments demonstrate that taurine treatment significantly enhances mitophagy, reduces oxidative stress, delays cell senescence, and promotes the removal of damaged mitochondria in nucleus pulposus cells (NPC). Additionally, taurine-mediated activation of the PINK1/Parkin pathway leads to improved mitochondrial homeostasis and slows the progression of disc degeneration. These findings provide new insights into the protective effects of taurine and highlight its potential as a therapeutic agent for IDD.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper addresses intervertebral disc degeneration (IDD), which is associated with aging and age-related decline in function. By focusing on the activation of mitophagy and mitochondrial dysfunction, it touches on mechanisms that could be linked to the aging process. However, while the findings are solid and contribute to understanding potential therapeutic approaches, they do not fundamentally address the root causes of aging or lifespan extension, limiting their overall impact.

Author of this paper? Send a correction.